ILK and cancer: It has been found that MUC16 containing truncated O-glycochains enhances migration of PDAC cells by specifically interacting with α4 and β1 integrin complexes on cancer cell membranes to activate the integrin-Fak signaling axis of integrin-linked kinase (ILK), which is enhanced by abnormal glycation structures [58].